The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Specialty Drug Distribution Market Research Report 2024
Synopsis
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The global Specialty Drug Distribution market was valued at US$ 267610 million in 2023 and is anticipated to reach US$ 546150 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
This report aims to provide a comprehensive presentation of the global market for Specialty Drug Distribution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Specialty Drug Distribution.
Report Scope
The Specialty Drug Distribution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Specialty Drug Distribution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Specialty Drug Distribution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma
Segment by Type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Segment by Application
Hospital and Clinic
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Specialty Drug Distribution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The global Specialty Drug Distribution market was valued at US$ 267610 million in 2023 and is anticipated to reach US$ 546150 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
This report aims to provide a comprehensive presentation of the global market for Specialty Drug Distribution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Specialty Drug Distribution.
Report Scope
The Specialty Drug Distribution market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Specialty Drug Distribution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Specialty Drug Distribution companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma
Segment by Type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Segment by Application
Hospital and Clinic
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Specialty Drug Distribution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Drug Distribution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 Rheumatoid Arthritis
1.2.4 Multiple Sclerosis
1.2.5 Hemophilia
1.2.6 Others
1.3 Market by Application
1.3.1 Global Specialty Drug Distribution Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Specialty Drug Distribution Market Perspective (2019-2030)
2.2 Specialty Drug Distribution Growth Trends by Region
2.2.1 Global Specialty Drug Distribution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Specialty Drug Distribution Historic Market Size by Region (2019-2024)
2.2.3 Specialty Drug Distribution Forecasted Market Size by Region (2025-2030)
2.3 Specialty Drug Distribution Market Dynamics
2.3.1 Specialty Drug Distribution Industry Trends
2.3.2 Specialty Drug Distribution Market Drivers
2.3.3 Specialty Drug Distribution Market Challenges
2.3.4 Specialty Drug Distribution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Specialty Drug Distribution Players by Revenue
3.1.1 Global Top Specialty Drug Distribution Players by Revenue (2019-2024)
3.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2019-2024)
3.2 Global Specialty Drug Distribution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Specialty Drug Distribution Revenue
3.4 Global Specialty Drug Distribution Market Concentration Ratio
3.4.1 Global Specialty Drug Distribution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Drug Distribution Revenue in 2023
3.5 Specialty Drug Distribution Key Players Head office and Area Served
3.6 Key Players Specialty Drug Distribution Product Solution and Service
3.7 Date of Enter into Specialty Drug Distribution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Drug Distribution Breakdown Data by Type
4.1 Global Specialty Drug Distribution Historic Market Size by Type (2019-2024)
4.2 Global Specialty Drug Distribution Forecasted Market Size by Type (2025-2030)
5 Specialty Drug Distribution Breakdown Data by Application
5.1 Global Specialty Drug Distribution Historic Market Size by Application (2019-2024)
5.2 Global Specialty Drug Distribution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Specialty Drug Distribution Market Size (2019-2030)
6.2 North America Specialty Drug Distribution Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Specialty Drug Distribution Market Size by Country (2019-2024)
6.4 North America Specialty Drug Distribution Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Specialty Drug Distribution Market Size (2019-2030)
7.2 Europe Specialty Drug Distribution Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Specialty Drug Distribution Market Size by Country (2019-2024)
7.4 Europe Specialty Drug Distribution Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Specialty Drug Distribution Market Size (2019-2030)
8.2 Asia-Pacific Specialty Drug Distribution Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Specialty Drug Distribution Market Size by Region (2019-2024)
8.4 Asia-Pacific Specialty Drug Distribution Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Specialty Drug Distribution Market Size (2019-2030)
9.2 Latin America Specialty Drug Distribution Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Specialty Drug Distribution Market Size by Country (2019-2024)
9.4 Latin America Specialty Drug Distribution Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Specialty Drug Distribution Market Size (2019-2030)
10.2 Middle East & Africa Specialty Drug Distribution Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Specialty Drug Distribution Market Size by Country (2019-2024)
10.4 Middle East & Africa Specialty Drug Distribution Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AmerisourceBergen
11.1.1 AmerisourceBergen Company Detail
11.1.2 AmerisourceBergen Business Overview
11.1.3 AmerisourceBergen Specialty Drug Distribution Introduction
11.1.4 AmerisourceBergen Revenue in Specialty Drug Distribution Business (2019-2024)
11.1.5 AmerisourceBergen Recent Development
11.2 Mckesson
11.2.1 Mckesson Company Detail
11.2.2 Mckesson Business Overview
11.2.3 Mckesson Specialty Drug Distribution Introduction
11.2.4 Mckesson Revenue in Specialty Drug Distribution Business (2019-2024)
11.2.5 Mckesson Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Detail
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Specialty Drug Distribution Introduction
11.3.4 Cardinal Health Revenue in Specialty Drug Distribution Business (2019-2024)
11.3.5 Cardinal Health Recent Development
11.4 Phoenix
11.4.1 Phoenix Company Detail
11.4.2 Phoenix Business Overview
11.4.3 Phoenix Specialty Drug Distribution Introduction
11.4.4 Phoenix Revenue in Specialty Drug Distribution Business (2019-2024)
11.4.5 Phoenix Recent Development
11.5 Medipal Holdings
11.5.1 Medipal Holdings Company Detail
11.5.2 Medipal Holdings Business Overview
11.5.3 Medipal Holdings Specialty Drug Distribution Introduction
11.5.4 Medipal Holdings Revenue in Specialty Drug Distribution Business (2019-2024)
11.5.5 Medipal Holdings Recent Development
11.6 Alliance Healthcare
11.6.1 Alliance Healthcare Company Detail
11.6.2 Alliance Healthcare Business Overview
11.6.3 Alliance Healthcare Specialty Drug Distribution Introduction
11.6.4 Alliance Healthcare Revenue in Specialty Drug Distribution Business (2019-2024)
11.6.5 Alliance Healthcare Recent Development
11.7 Sinopharm
11.7.1 Sinopharm Company Detail
11.7.2 Sinopharm Business Overview
11.7.3 Sinopharm Specialty Drug Distribution Introduction
11.7.4 Sinopharm Revenue in Specialty Drug Distribution Business (2019-2024)
11.7.5 Sinopharm Recent Development
11.8 Express Scripts
11.8.1 Express Scripts Company Detail
11.8.2 Express Scripts Business Overview
11.8.3 Express Scripts Specialty Drug Distribution Introduction
11.8.4 Express Scripts Revenue in Specialty Drug Distribution Business (2019-2024)
11.8.5 Express Scripts Recent Development
11.9 Shanghai Pharma
11.9.1 Shanghai Pharma Company Detail
11.9.2 Shanghai Pharma Business Overview
11.9.3 Shanghai Pharma Specialty Drug Distribution Introduction
11.9.4 Shanghai Pharma Revenue in Specialty Drug Distribution Business (2019-2024)
11.9.5 Shanghai Pharma Recent Development
11.10 Anda
11.10.1 Anda Company Detail
11.10.2 Anda Business Overview
11.10.3 Anda Specialty Drug Distribution Introduction
11.10.4 Anda Revenue in Specialty Drug Distribution Business (2019-2024)
11.10.5 Anda Recent Development
11.11 Jointown
11.11.1 Jointown Company Detail
11.11.2 Jointown Business Overview
11.11.3 Jointown Specialty Drug Distribution Introduction
11.11.4 Jointown Revenue in Specialty Drug Distribution Business (2019-2024)
11.11.5 Jointown Recent Development
11.12 Max Pharma
11.12.1 Max Pharma Company Detail
11.12.2 Max Pharma Business Overview
11.12.3 Max Pharma Specialty Drug Distribution Introduction
11.12.4 Max Pharma Revenue in Specialty Drug Distribution Business (2019-2024)
11.12.5 Max Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
